Rani Therapeutics Holdings Inc (RANI)
Rani Therapeutics Holdings is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. Co. has developed the RaniPill capsule, which is its novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine.
| Company Name: |
Rani Therapeutics Holdings Inc |
| Website: |
www.ranitherapeutics.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding RANI: |
2 |
| Total Market Value Held by ETFs: |
$4.65M |
| Total Market Capitalization: |
$175.00M |
| % of Market Cap. Held by ETFs: |
2.66% |
|
|
April 18, 2024 • 2:17 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|
Free RANI Email Alerts:
